Application of antisense oligodeoxynucleotides for organ transplantation

Transplantation Proceedings

Volumn 30, Issue 5, 1998, Pages 2142-2145

  Stepkowski, S M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; BREQUINAR; CYCLOSPORIN A; INTERCELLULAR ADHESION MOLECULE 1; IP 1082; IP 3082; IP 7253; IP 9125; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1 ANTIBODY; MONOCLONAL ANTIBODY; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; RAPAMYCIN; UNCLASSIFIED DRUG;

BLOOD CLOTTING DISORDER; CARDIOTOXICITY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG DISTRIBUTION; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; DRUG POTENTIATION; DRUG PROTEIN BINDING; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; INTRADERMAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOID HYPERPLASIA; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SPLENOMEGALY;

ANIMALS; ANTIBODIES, MONOCLONAL; DRUG DESIGN; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERCELLULAR ADHESION MOLECULE-1; MICE; OLIGONUCLEOTIDES, ANTISENSE; ORGAN TRANSPLANTATION; RATS;

EID: 0031683146     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00567-3     Document Type: Conference Paper

References (29)

1. Crooke RM, et al: J Pharmacol Exp Ther 275:462, 1995
2. Crooke S: In Teicher BA (ed): Cancer Therapeutics: Experimental and Clinical Agents. Totowa, NJ: Humana; 1997, p 229
3. Crooke ST: In Cuello AC, Collier B (eds). Pharmacological Sciences: Perspectives for Research and Therapy in the Late 1990s. Basel, Switzerland: Birkhauser Verlag; 1996, p 393
4. Mirabelli CK, Crooke ST: In Crooke ST, Lebleu B (eds). Antisense Research and Applications. Boca Raton, FL: CRC Press; 1993, p 7
5. Crooke ST: Annu Rev Pharmacol Toxicol 32:329, 1992
6. Akhtar S, Kole R, Juliano RL: Life Sci 49:1793, 1991
7. Milligan JF, Matteucci MD, Martin JC: J Med Chem 36:1923, 1993
8. Hoke GD, Draper K, Freier SM, et al: Nucleic Acids Res 19:5743, 1991
9. Gao W-Y, Han FS, Storm C, et al: Mol Pharmacol 41:223, 1992
10. Cossum PA, Sasmor H, Dellinger D, et al: J Pharmacol Exp Ther 267:1181, 1993
11. Crooke ST, Graham MJ, Zuckerman JE, et al: J Pharmacol Exp Ther 277:923, 1996
12. Cossum PA, Truong L, Owens SR, et al: J Pharmacol Exp Ther 269:89, 1994
13. Crooke ST, Grillone LR, Tendolkar A, et al: Clin Pharmacol Ther 56:641, 1994
14. Glover JM, Leeds JM, Mant TG, et al: J Pharmacol Exp Ther 282:1173, 1997
15. Takakura Y, Mahato RI, Yoshida M, et al: Antisense Nucleic Acid Drug Del 6:177, 1996
16. Henry SP, Boite H, Auletta C, et al: Toxicology 1997
17. Henry SP, Giclas PC, Leeds J, et al: J Pharmacol Exp Ther 281:810, 1997
18. Henry SP, Novotny W, Leeds J, et al: Antisense Neuclic Acid Drug Del (in press)
19. Bennett CF, Crooke ST: In Henderson B, Bodmer MW (eds): Therapeutic Modulation of Cytokines. Boca Raton, FL: CRC Press, 1996, p 171
20. Simons M, Edelman ER, DeKeyser JL, et al: Nature 359:67, 1992
21. Osen-Sand A, Catsicas M, Staple JK, et al: Nature 364:445, 1993
22. Ratajczak MZ, Kant JA, Luger SM, et al: Proc Natl Acad Sci USA 89:11823, 1992
23. Katajima I, Shinohara T, Bilakovics J, et al: Science 258: 1792, 1992
24. Rothlein R, Dustin ML, Marlin SD, et al: J Immunol 137:1270, 1996
25. Springer TA: Nature 346:425, 1990
26. Springer TA: Annu Rev Cell Biol 6:359, 1990
27. Stepkowski SM, Tu Y, Condon T, et al: J Immunol 153:5336, 1994
28. Cosimi AB, Conti D, Delmonico FL, et al: J Immunol 144:4604, 1990
29. Haug CER, Colvin B, Delmonico FL, et al: Transplantation 55:766, 1993